A roadmap to precision treatments for familial pulmonary fibrosis
Open Access
- 7 May 2024
- journal article
- review article
- Published by Elsevier in EBioMedicine
- Vol. 104, 105135
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosisRespiratory Medicine, 2011
- Idiopathic Pulmonary Fibrosis: Update on Genetic DiscoveriesProceedings of the American Thoracic Society, 2011
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsThe Lancet, 2011
- SFTPC Mutations in Patients with Familial Pulmonary Fibrosis: Combined with Emphysema?American Journal of Respiratory and Critical Care Medicine, 2011
- The European IPF Network: towards better care for a dreadful diseaseEuropean Respiratory Journal, 2011
- Expression of therapeutic proteins after delivery of chemically modified mRNA in miceNature Biotechnology, 2011
- Wild-derived inbred mouse strains have short telomeresNucleic Acids Research, 2000
- Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNACell, 1997
- A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds.Journal of Clinical Investigation, 1994
- Pathogenesis of “fibrosis” in interstitial pneumonia: An electron microscopic studyHuman Pathology, 1985